Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case report

RATIONALE: Marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) has an indolent natural course and disseminates slowly. However, there is currently no consensus regarding the optimal treatment strategy for relapsed/refractory MALT lymphomas. Lenalidomide-bendamustin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhencang, Wu, Pengqiang, Wang, Fujue, Tao, Huan, Chen, Yingying, Gao, Jie, Chen, Dengke, Jia, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896437/
https://www.ncbi.nlm.nih.gov/pubmed/35244050
http://dx.doi.org/10.1097/MD.0000000000028938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896437/
https://www.ncbi.nlm.nih.gov/pubmed/35244050
http://dx.doi.org/10.1097/MD.0000000000028938

Ejemplares similares